ATORVASTATIN Mepha Teva cpr pell 20 mg 100 pce

7680613640232 CH-61364 C10AA05 07.12.0.

Reimbursement limitations:

SORTIS

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

ATORVASTATIN Mepha Teva cpr pell 20 mg 100 pce
ATORVASTATIN Mepha Teva cpr pell 20 mg 100 pce
ATORVASTATIN Mepha Teva cpr pell 20 mg 100 pce
1 / 3
google

Details

Product number
6136402
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
atorvastatinum 20 mg ut atorvastatinum calcicum trihydricum, mannitolum, cellulosum microcristallinum, crospovidonum, natrii carbonas, povidonum, methioninum, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 6000, pro compresso obducto corresp. natrium 5.73 mg.

Articles (1)

Atorvastatin-Mepha Teva 20 mg, Filmtabletten
Filmtabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/08/2025
Patient information leaflet
Français
26/08/2025
Patient information leaflet
Italien
26/08/2025
Professional SmPC
Allemand
26/08/2025
Professional SmPC
Français
26/08/2025
Professional SmPC
Italien
26/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
5.73 MG Substance HBESI

Reimbursement information

Public price
CHF 62.90
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/06/2012

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
61364
Drug name
Atorvastatin-Mepha Teva, Filmtabletten
Galenic form
FILM
ATC Code
C10AA05
Authorization status
Z
Dispensation category
B
First authorization
05/07/2011
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
ATORVASTATIN Mepha Teva cpr pell 20 mg 100 pce
Description (DE)
ATORVASTATIN Mepha Teva Filmtabl 20 mg 100 Stk
Market launch
05/07/2011
Market withdrawal
31/07/2025
Narcotic (BTM)
No

Original drug

Sortis, Filmtabletten
CHF 37.75
View original

Other packaging sizes

ATORVASTATIN Mepha Teva cpr pell 10 mg 30 pce
30 TABL
View
ATORVASTATIN Mepha Teva cpr pell 10 mg 100 pce
100 TABL
View
ATORVASTATIN Mepha Teva cpr pell 10 mg bte 100 pce
100 TABL
View